Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7250169

    Anti-tumor activity of Ea-4-peptide of pro-IGF-1

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7247316

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7244450

    Compositions and methods for treating lymphoma

    The Board of Regents of the University of Texas System · Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7238525

    Strategy for leukemia therapy

    The Regents of the University of California · Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7232887

    Melanoma antigens and their use in diagnostic and therapeutic methods

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7229770

    YKL-40 as a marker and prognostic indicator for cancers

    The Regents of the University of California · Granted Tue Jun 12 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7220730

    Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7217795

    Tumor suppressor designated TS10q23.3

    The Board of Regents of the University of Texas System · Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7205334

    Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7204996

    Method of cancer treatment

    The Board of Regents of the University of Texas System · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7204982

    Compositions and methods for treatment and detection of multiple cancers

    The Regents of the University of California · Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7202045

    Detection and treatment of cancers of the lung

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7192704

    Methods for detection and treatment of neural cancers

    The Regents of the University of California · Granted Tue Mar 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7189393

    Recombinant anti-tumor RNAse

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7183389

    Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)

    Molecular Discoveries, Inc. · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7183388

    Anti-MUC-1 single chain antibodies for tumor targeting

    The Regents of the University of California · Granted Tue Feb 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7179588

    Assay for the detection of paclitaxel resistant cells in human tumors

    The Board of Regents of the University of Texas System · Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7175981

    Method of diagnosing stage or aggressiveness of breast and prostate cancer based on levels of fatty acid binding proteins

    The United States of America as represented by the Secretary of the Army · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7175830

    Imaging of drug accumulation as a guide to antitumor therapy

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7169384

    Tumor suppressor CAR-1

    The Board of Regents of the University of Texas System · Granted Tue Jan 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7166704

    Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7163925

    p16 expression constructs and their application in cancer therapy

    The Board of Regents of the University of Texas System · Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7160868

    Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors

    Northwest Hospital · Granted Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7150869

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7151100

    Indole compounds useful for the treatment of cancer

    The Regents of the University of California · Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7148201

    Use of human plasma hyaluronidase in cancer treatment

    The Regents of the University of California · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7148196

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7144867

    Anticancer glycoside compounds

    Northwestern University · Granted Tue Dec 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7141661

    Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7141234

    Imaging of drug accumulation as a guide to antitumor therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7141603

    Antitumor agents

    The Regents of the University of California · Granted Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7135303

    Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7125969

    ETS-related gene overexpressed in human breast and epithelial cancers

    The Regents of the University of California · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7125541

    Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

    THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7122714

    Mouse models of human prostate cancer

    The Regents of the University of California · Granted Tue Oct 17 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7118747

    AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents

    Pacific Northwest Biotechnology Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7119223

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7118738

    Recombinant pox virus for immunization against MUC1 tumor-associated antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7115360

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7112317

    Combined methods and compositions for tumor vasculature targeting and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Sep 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7109303

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7108986

    Glypican-1 in human breast cancer

    The Regents of the University of California · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7109188

    Methods and compositions for treating atheroma, tumors and other neoplastic tissue

    The Board of Regents of the University of Texas System · Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7105561

    Use of etodolac for the treatment of prostate cancer

    The Regents of the University of California · Granted Tue Sep 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7101557

    Combined tissue factor methods for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7098306

    Method and compositions for treating hepatocellular cancer

    The Regents of the University of California · Granted Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7084239

    Cancer peptides of NY-ESO-1/CAG-3

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7071168

    Anti-cancer compounds and methods related thereto

    The Regents of the University of Colorado · Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.